Kneu Health transforms smart phones into clinical-grade monitors to keep a tab on neurological conditions like Parkinson’s and dementia.
Kneu Health has raised $5.6M in total funding. The most recent round was Seed. The last funding was announced in October 2025.
Kneu Health's investors include Oxford Science Enterprises, Cedars Sinai, Jameel Investment Management Company, GK Goh Ventures, SXSW London.
Kneu Health is headquartered in London, United Kingdom.
Kneu Health transforms smart phones into clinical-grade monitors to keep a tab on neurological conditions like Parkinson’s and dementia.
Kneu Health is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Kneu Health — Funding & Investors." VCBacked, October 9, 2025, https://www.vcbacked.co/company/kneu-health. Accessed August 14, 2026.
VCBacked. (2025). Kneu Health — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/kneu-health
{{cite web |title=Kneu Health — Funding & Investors |url=https://www.vcbacked.co/company/kneu-health |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated